Bengaluru's Dognosis trains five dogs to detect cancer from breath with 90.8% accuracy. This method sidesteps traditional regulatory hurdles for early cancer screening by calling its service a "triaging" tool. They target the 99% of Indians currently unscreened, by undercutting expensive and invasive tests.
How We Got Here
Dognosis conducted trials across six Karnataka hospitals between March 2024 and June 2025, involving over 1,500 participants. Their first health-monitoring service, Breatheeasy, launches next year, positioned as a "triaging" tool.
The Numbers
- The test uses a Bayesian model, combining dog responses with patient data like age, family history, and tobacco use.
- Dognosis claims just 15 dogs can screen 2,50,000 patients annually.
- The trial results (90.8% sensitivity, 91.3% specificity) were published in the Journal of Clinical Oncology in June.
- Existing D2C wellness players like Nura and Cent offer full-body scans, which often lead to incidental findings and anxiety.
- Cancer incidence in India is growing by about 2% per year.
What Happens Next
🇮🇳 Why This Matters for India
For healthcare providers in Tier-2 cities like Nashik and Kochi, this offers an inexpensive, non-invasive screening option for the rising 2% annual cancer incidence.
The Take
Dognosis found a smart regulatory hack with "triaging," but the real innovation is their Bayesian model, not just the dogs. This approach might eventually force a regulatory re-evaluation of diagnostic tools in India.
Source:
The Ken ↗